Collagen II/hyaluronan/chondroitin-6-sulfate tri-copolymer scaffold for nucleus pulposus tissue engineering

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 92, Issue 2, 2010, Pages 322-331

  Huang, Bo ^a   Li, Chang Qing ^a   Zhou, Yue ^a   Luo, Gang ^a   Zhang, Chuan Zhi ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Chondroitin 6 sulfate; Collagen II; Hyaluronan; Nucleus pulposus; Tissue engineering

Indexed keywords

ALTERNATIVE MATERIALS; AMINOPROPYL; CARBODIIMIDES; CHONDROITIN; COLLAGEN I; COLLAGEN II; COPOLYMER SCAFFOLDS; EXTRACELLULAR MATRICES; HYALURONAN; IN-VIVO; MONOLAYER CELLS; N-HYDROXYSUCCINIMIDE; NUCLEUS PULPOSUS; SEM; SULFATED GLYCOSAMINOGLYCANS;

BIOACTIVITY; CELL CULTURE; COLLAGEN; COPOLYMERIZATION; ELECTRIC DISCHARGE MACHINING; ENGINEERING; GENE EXPRESSION; MONOLAYERS; SCANNING ELECTRON MICROSCOPY; TISSUE; TISSUE ENGINEERING;

SCAFFOLDS;

1 (3 DIMETHYLAMINOPROPYL) 3 ETHYLCARBODIIMIDE; AGGRECAN; CHONDROITIN 6 SULFATE; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 2 HYALURONAN CHONDROITIN 6 SULFATE TRICOPOLYMER; COPOLYMER; GLYCOSAMINOGLYCAN POLYSULFATE; HYALURONIC ACID; N HYDROXYSUCCINIMIDE; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION; NONHUMAN; NUCLEUS PULPOSUS; RABBIT; SCANNING ELECTRON MICROSCOPY; TISSUE ENGINEERING;

ANIMALS; BIOCOMPATIBLE MATERIALS; BISBENZIMIDAZOLE; CELL PROLIFERATION; CELL SURVIVAL; CHONDROITIN SULFATES; COLLAGEN TYPE II; COLORING AGENTS; DNA; EXTRACELLULAR MATRIX; GENE EXPRESSION; HYALURONIC ACID; IMMUNOHISTOCHEMISTRY; METHYLENE BLUE; MICROSCOPY, ELECTRON, SCANNING; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SINCALIDE; TISSUE SCAFFOLDS;

EID: 74749106761     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31518     Document Type: Article

References (41)

1. Andersson GB. Epidemiologic aspects on low-back pain in industry. Spine 1981;6:53-60.
2. Devereaux M. Low back pain. Med Clin North Am 2009;93:477-501.
3. Picavet HSJ, Schouten JSAG. Musculoskeletal pain in the Netherlands: Prevalences, consequences and risk groups, the DMC3-study. Pain 2003;102:167-178.
4. Clinical Standards Advisory Group Back Pain: Report of a Clinical Standards Advisory Group on Back Pain. London: HMSO; 1994.
5. Van Geen JW, Edelaar MJ, Janssen M, Van Eijk JT. The long-term effect of multidisciplinary back training: A systematic review. Spine 2007;32:249-255.
6. Norlund A, Ropponen A, Alexanderson K. Multidisciplinary interventions: Review of studies of return to work after rehabilitation for low back pain. J Rehabil Med 2009;41:115-121.
7. Maniadakis N, Gray A. The economic burden of back pain in the UK. Pain 2000;84:95-103.
8. Ekman M, Johnell O, Lidgren L. The economic cost of low back pain in Sweden in 2001. Acta Orthop 2005;76:275-284.
9. Dagenais S, Caro J, Haldeman S. A systematic review of low back pain cost of illness studies in the United States and internationally. Spine J 2008;8:8-20.
10. Schwarzer AC, Aprill CN, Derby R, Fortin J, Kine G, Bogduk N. The prevalence and clinical features of internal disc disruption in patients with chronic low back pain. Spine 1995;20:1878-1883.
11. Yasuma T, Koh S, Okamura T, Yamauchi Y. Histological changes in aging lumbar intervertebral discs. Their role in protrusions and prolapses. J Bone Joint Surg Am 1990;72:220-229.
12. Olson EJ, Hanley EN, Rudert MJ, Baratz ME. Vertebral column allografts for the treatment of segmental spine defects. An experimental investigation in dogs. Spine 1991;16:1081-1088.
13. Nomura T, Mochida J, Okuma M, Nishimura K, Sakabe K. Nucleus pulposus allograft retards intervertebral disc degeneration. Clin Orthop Relat Res 2001;94-101.
14. Luk KD, Ruan DK, Lu DS, Fei ZQ. Fresh frozen intervertebral disc allografting in a bipedal animal model. Spine 2003;28:864-869. Discussion 870
15. Luk KD, Ruan DK. Intervertebral disc transplantation: A biological approach to motion preservation. Eur Spine J 2008; 17(Suppl 4):504-510.
16. Thomas J, Gomes K, Lowman A, Marcolongo M. The effect of dehydration history on PVA/PVP hydrogels for nucleus pulposus replacement. J Biomed Mater Res B Appl Biomater 2004;69:135-140.
17. Van Ooij A, Oner FC, Verbout AJ. Complications of artificial disc replacement: A report of 27 patients with the SB Charite disc. J Spinal Disord Tech 2003;16:369-383.
18. Paesold G, Nerlich AG, Boos N. Biological treatment strategies for disc degeneration: Potentials and shortcomings. Eur Spine J 2007;16:447-468.
19. Seguin CA, Grynpas MD, Pilliar RM, Waldman SD, Kandel RA. Tissue engineered nucleus pulposus tissue formed on a porous calcium polyphosphate substrate. Spine 2004;29:1299-1306. Discussion 1306-1307
20. Rong Y, Sugumaran G, Silbert J, Spector M. Proteoglycans synthesised by canine intervertebral disc cells grown in a type I collagen-glycosaminoglycan matrix. Tissue Eng 2002;8:1037-1047.
21. Sato M, Kikuchi M, Ishihara M, Asazuma T, Kikuchi T, Masuoka K, Hattori H, Fujikawa K. Tissue engineering of the intervertebral disc with cultured annulus fibrosus cells using atelocollagen honeycomb-shaped scaffold with a membrane seal (ACHMS scaffold). Med Biol Eng Comput 2003;41:365-371.
22. Alini M, Li W, Markovic P, Aebi M, Spiro RC, Roughley PJ. The potential and limitations of a cell-seeded collagen/hyaluronan scaffold to engineer an intervertebral disc-like matrix. Spine 2003;28:446-454.
23. Yang SH, Chen PQ, Chen YF, Lin FH. Gelatin/chondroitin-6-sulfate copolymer scaffold for culturing human nucleus pulposus cells in vitro with production of extracellular matrix. J Biomed Mater Res B Appl Biomater 2005;74:488-494.
24. Yang SH, Chen PQ, Chen YF, Lin FH. An in-vitro study on regeneration of human nucleus pulposus by using gelatin/ chondroitin-6-sulfate/hyaluronan tri-copolymer scaffold. Artif Organs 2005;29:806-814.
25. Perka C, Arnold U, Spitzer RS, Lindenhayn K. The use of fibrin beads for tissue engineering and subsequential transplantation. Tissue Eng 2001;7:359-361.
26. Chiba K, Andersson GB, Masuda K, Thonar EJ. Metabolism of the extracellular matrix formed by intervertebral disc cells cultured in alginate. Spine 1997;22:2885-2893.
27. Baer AE, Wang JY, Kraus VB, Setton LA. Collagen gene expression and mechanical properties of intervertebral disc cell-alginate cultures. J Orthop Res 2001;19:2-10.
28. Wakatsuki T, Elson EL. Reciprocal interactions between cells and extracellular matrix during remodeling of tissue constructs. Biophys Chem 2003;100:593-605.
29. Gruber HE, Hanley EN. Biologic strategies for the therapy of intervertebral disc degeneration. Expert Opin Biol Ther 2003;3:1209-1214.
30. Sechriest VF, Miao YJ, Niyibizi C, Westerhausen-Larson A, Matthew HW, Evans CH, Fu FH, Suh JK. GAG-augmented polysaccharide hydrogel: A novel biocompatible and biodegradable material to support chondrogenesis. J Biomed Mater Res 2000;49:534-541.
31. Kitano T, Zerwekh JE, Usui Y, Edwards ML, Flicker PL, Mooney V. Biochemical changes associated with the symptomatic human intervertebral disk. Clin Orthop Relat Res 1993;372-377.
32. Kawasaki K, Ochi M, Uchio Y, Adachi N, Matsusaki M. Hyaluronic acid enhances proliferation and chondroitin sulfate synthesis in cultured chondrocytes embedded in collagen gels. J Cell Physiol 1999;179:142-148.
33. Charulatha V, Rajaram A. Influence of different crosslinking treatments on the physical properties of collagen membranes. Biomaterials 2003;24:759-767.
34. Pieper JS, Hafmans T, Veerkamp JH, Van Kuppevelt TH. Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects. Biomaterials 2000;21:581-593.
35. Lee CR, Grodzinsky AJ, Spector M. The effects of cross-linking of collagen-glycosaminoglycan scaffolds on compressive stiffness, chondrocyte-mediated contraction, proliferation and biosynthesis. Biomaterials 2001;22:3145-3154.
36. O'brien FJ, Harley BA, Yannas IV, Gibson L. Influence of freezing rate on pore structure in freeze-dried collagen-GAG scaffolds. Biomaterials 2004;25:1077-1086.
37. Sakai D, Mochida J, Iwashina T, Watanabe T, Suyama K, Ando K, Hotta T. Atelocollagen for culture of human nucleus pulposus cells forming nucleus pulposus-like tissue in vitro: Influence on the proliferation and proteoglycan production of HNPSV-1 cells. Biomaterials 2006;27:346-353.
38. Halloran DO, Grad S, Stoddart M, Dockery P, Alini M, Pandit AS. An injectable cross-linked scaffold for nucleus pulposus regeneration. Biomaterials 2008;29:438-447.
39. Gruber HE, Leslie K, Ingram J, Norton HJ, Hanley EN. Cell-based tissue engineering for the intervertebral disc: In vitro studies of human disc cell gene expression and matrix production within selected cell carriers. Spine J 2004;4:44-55.
40. Roughley PJ. Biology of intervertebral disc aging and degeneration: Involvement of the extracellular matrix. Spine 2004;29:2691-2699.
41. Hunter CJ, Matyas JR, Duncan NA. The notochordal cell in the nucleus pulposus: A review in the context of tissue engineering. Tissue Eng 2003;9:667-677.